[98F10-98F10];[99B9-99B9];
A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
98F10;99B9
Breakpoint based on release 3 sequence coordinate from Thibault et al., 2004, Supplementary Table 2 (FBrf0174227) or 3 (FBrf0174228), converted to release 5 coordinate.
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
Df(3R)BSC501 heterozygotes show an abnormal and highly penetrant paralysis phenotype upon exposure to 10[o]C, but not 14[o]C, temperatures, despite of an apparently normal recovery time from paralysis upon shift to room temperature, as compared to wild-type controls.
The presence of P+PBac{XP5.WH5}BSC501 was verified using the PCR methods and primers described in FBrf0175003.
The cytological breakpoints of Df(3R)BSC501 predicted from the Release 5 genomic coordinates of the progenitor P{XP}d00762 and PBac{WH}CG7593f05191 insertion sites are 98F10;99B9.